MOH
Molina Healthcare, Inc.
NYSE · Healthcare · Medical - Healthcare Plans · US
$200.33
−1.27%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 44.5B | 45.4B | 40.6B | 34.1B | 32.0B |
| Cost of Revenue | 29.1B | 39.5B | 35.9B | 29.7B | 28.0B |
| Gross Profit | 15.4B | 5.9B | 4.7B | 4.3B | 3.9B |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 3.0B | 3.0B | 2.7B | 2.5B | 2.3B |
| General & Admin Expense | 3.0B | 3.0B | 2.7B | 2.5B | 2.3B |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 12.1B | 2.1B | 286.0M | 299.0M | 234.0M |
| Total Operating Expenses | 15.1B | 5.2B | 3.0B | 2.8B | 2.5B |
| Cost and Expenses | 44.2B | 44.6B | 38.9B | 32.5B | 30.6B |
| Operating Income (EBIT) | 296.0M | 781.0M | 1.7B | 1.6B | 1.4B |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | 209.0M | 192.0M | 118.0M | 109.0M | 110.0M |
| Net Interest Income | (209.0M) | (192.0M) | (118.0M) | (109.0M) | (110.0M) |
| Other Non-Op Income/Expense | (302.0M) | (192.0M) | (118.0M) | (109.0M) | (318.0M) |
| Non-Operating Income (excl Interest) | 93.0M | — | — | — | 208.0M |
| EBT (Pre-Tax Income) | (6.0M) | 589.0M | 1.6B | 1.5B | 1.1B |
| Income Tax Expense | 1.0M | 117.0M | 410.0M | 373.0M | 271.0M |
| Bottom Line | |||||
| Net Income | (7.0M) | 472.0M | 1.2B | 1.1B | 792.0M |
| Earnings from Cont. Ops | (7.0M) | 472.0M | 1.2B | 1.1B | 792.0M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (7.0M) | 472.0M | 1.2B | 1.1B | 792.0M |
| Per Share | |||||
| Basic EPS | $0.16 | $8.93 | $20.52 | $18.71 | $13.70 |
| Diluted EPS | $0.19 | $8.92 | $20.42 | $18.78 | $13.54 |
| Revenue Per Share | $867.88 | $894.32 | $708.19 | $586.44 | $553.18 |
| Shares | |||||
| Basic Shares Outstanding | 51.3M | 50.8M | 57.4M | 58.1M | 57.8M |
| Diluted Shares Outstanding | 51.3M | 50.8M | 57.7M | 58.1M | 58.5M |
| Profitability Metrics | |||||
| EBITDA | 371.0M | 976.0M | 1.9B | 1.7B | 1.3B |
| D&A | 168.0M | 195.0M | 186.0M | 171.0M | 176.0M |
| EBIT | 203.0M | 781.0M | 1.7B | 1.6B | 1.2B |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026